# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-139508
Filing Date
2017-04-26
Accepted
2017-04-26 16:17:58
Documents
3
Period of Report
2017-06-12
Effectiveness Date
2017-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d356798ddef14a.htm | DEF 14A | 749557
2 | GRAPHIC | g356798dsp001.jpg | GRAPHIC | 305568
3 | GRAPHIC | g356798dsp002.jpg | GRAPHIC | 176320
| Complete submission text file | 0001193125-17-139508.txt |  | 1414567

Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 17784578
SIC: 2834 Pharmaceutical Preparations